Avant Brands (FRA:1BU) Moat Score: 2/10 (As of Jul. 07, 2026)


FRA:1BU Avant Brands Inc FRA:1BU
37 GF Score
Price €0.34
GF Value €0.74
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Avant Brands Moat Score?

Avant Brands FRA:1BU 37 Moat Score is 2 as of Jul. 07, 2026. GuruFocus rates FRA:1BU with a GF Score™ of 37/100 and a GF Value™ of €0.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,032 Drug Manufacturers companies, Avant Brands ranks better than 81.59% on this metric.

Avant Brands has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Avant Brands has No Moat: Avant Brands operates in the competitive cannabis industry with limited brand strength and no significant regulatory advantages, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Avant Brands might have No Moat - Very weak/transient advantages.

Avant Brands  (FRA:1BU) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Avant Brands Moat Score Related Terms

FRA:1BU vs ZTS, UTHR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avant Brands Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avant Brands's Moat Score distribution charts can be found below:

* The bar in red indicates where Avant Brands's Moat Score falls into.


FRA:1BU
37GF Score
Avant Brands Inc FRA:1BU
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Avant Brands (FRA:1BU) has a Moat Score of 2 as of Jul. 07, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Avant Brands ranks #190 out of 1032 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is Avant Brands' Moat Score too high?
Avant Brands' current Moat Score is 2. Based on the distribution chart, Avant Brands ranks #190 out of 1032 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Avant Brands has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #190 out of 1032 companies for Moat Score. This places Avant Brands in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Avant Brands's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (FRA:1BU) is currently considered Possible Value Trap. The stock's GF Value™ is €0.74, compared to a current price of €0.34 — trading 54.3% below its estimated fair value. The current Moat Score is 2. Avant Brands' overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Avant Brands (FRA:1BU), the current Moat Score is 2 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avant Brands (FRA:1BU) Overvalued in 2026?

Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued. The current stock price of €0.34 is trading 54.3% below its estimated GF Value™ of €0.74. GuruFocus considers Avant Brands to be Possible Value Trap.

Key valuation signals for FRA:1BU:

  • Moat Score: 2
  • GF Value™: €0.74 vs. price of €0.34 (54.3% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the FRA:1BU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avant Brands Business Description

Other Exchanges AVTBF:USAAVNT:Canada
Address 1700 Dickson Avenue, Suite 910, Kelowna, BC, CAN, V1Y 0L5
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
37GF Score

Get the complete analysis for FRA:1BU

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price
€0.74
GF Value